new-recommended-broker-banner new-recommended-broker-banner

Here’s Why Redx Pharma Shares Surged 78.6% Today

Updated: 9 Sep 2020

Shares of Redx Pharma Plc (LON: REDX) surged 78.6% higher today after the company announced a collaboration with Jazz Pharmaceuticals, a US company, for the discovery and development of two cancer therapies.

Redx Pharma will receive an upfront payment of US$10 million and a similar amount in the second year if the research is still continuing. The deal also includes US$400 million in milestone payments and staggered royalties.

The company will lead the discovery and preclinical development of the two cancer therapies.

new-recommended-broker-banner

Today’s deal follows the sale of Redx’s preclinical pan-RAF inhibitor programme to Jazz for the potential treatment of RAF and RAS mutant tumours in July 2019.

Lisa Anson, REdx pharma’s CEO said: “We are extremely pleased to announce this new collaboration with Jazz, which expands on our already strong working relationship, built through a year of collaboration on the pan-RAF inhibitor programme.  This new agreement reinforces Redx’s strong position as a successful research partner and its expertise in medicinal chemistry and drug design.”

Redx Pharma share price

Tradingview chart of Redx Pharma share price 09092020

Redx Pharma shares today surged 78.6% to trade at 93.6p having ended Tuesday’s session trading at 52.4p.

People who read this also read:

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 75 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .